B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat leukemias: experimental combo enters human testing
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a new drug, ABL001, when combined with three existing leukemia medications. It is for adults with two specific, aggressive types of blood cancer (BCR-ABL+ B-ALL or CML in blast crisis). The main goal is to see if this …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Marlise Luskin, MD • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New 'Ready-Made' cancer therapy trial seeks to tame tough blood cancers
Disease control Recruiting nowThis early-stage trial is testing the safety and early effectiveness of a new type of CAR T-cell therapy called azer-cel in adults whose B-cell blood cancers have returned or not responded to prior treatments. The therapy uses donor immune cells (allogeneic) engineered to target …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial offers hope for Tough-to-Treat leukemia patients
Disease control Recruiting nowThis study is testing a new drug called YK012 for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has returned or hasn't responded to previous treatments. The trial has two parts: first finding the safest dose, then seeing if the drug shows signs of fighting the canc…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Off-the-Shelf immune cells battle tough leukemia in new trial
Disease control Recruiting nowThis study is testing a new type of cell therapy called UCART22 for adults with B-cell acute lymphoblastic leukemia (B-ALL) that has returned or not responded to standard treatments. The main goals are to find a safe and effective dose and see if the treatment can help control th…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Cellectis S.A. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Boosting the Body's fight: new therapy aims to recharge Cancer-Killing cells in tough leukemia
Disease control Recruiting nowThis study is for children and young adults (ages 1-39) whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to treatment, and whose previous CAR-T cell therapy stopped working early. Researchers want to see if adding a different type of immune cell, called…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with tough leukemia: donor cell therapy trial opens
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for children and young adults whose B-cell leukemia has come back or hasn't responded to other treatments. Doctors are using immune cells from a donor, engineered to target the cancer, to see if this approach is safe an…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for older leukemia patients: gentler treatment trial seeks to control cancer
Disease control Recruiting nowThis study is testing whether a new drug called blinatumomab, given as an injection under the skin, works well and is safe when combined with lower-dose chemotherapy for older adults or those too frail for standard intensive chemotherapy who have a type of blood cancer called B-c…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Trial aims to Fine-Tune powerful cancer treatment for kids
Disease control Recruiting nowThis study is testing if adjusting the dose of a chemotherapy drug (fludarabine) based on a patient's individual metabolism improves the effectiveness of a subsequent CAR-T cell therapy for children and young adults with relapsed or hard-to-treat B-cell acute lymphoblastic leukem…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New 'Sandwich' therapy aims to control leukemia with fewer risks
Disease control Recruiting nowThis study is testing a new treatment approach for adults with B-cell acute lymphoblastic leukemia (B-ALL) who cannot or choose not to have a standard donor stem cell transplant. Researchers are combining an immunotherapy drug called blinatumomab with a transplant using the patie…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New 'Off-the-Shelf' gene therapy aims to outsmart tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new, one-time gene therapy called VNX-101 for patients whose B-cell blood cancers have returned or not responded to other treatments. The therapy is designed to help the patient's own immune system continuously fight cancer cells. Researchers w…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Vironexis Biotherapeutics Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Double-Punch CAR-T trial aims to stop Leukemia's comeback in kids
Disease control Recruiting nowThis study is testing a new, two-part version of CAR-T cell therapy for children and young adults whose B-cell leukemia has come back or not responded to other treatments. It combines two specially engineered immune cell therapies to try to prevent the cancer from returning. The …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for kids with tough cancers: experimental drug trial opens
Disease control Recruiting nowThis study is testing a new drug called zilovertamab vedotin in children and young adults whose cancers have come back or haven't responded to standard treatments. It will enroll about 90 participants aged 1 year and older with specific blood cancers or solid tumors. The main goa…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for tough leukemia: testing a powerful drug trio in kids and young adults
Disease control Recruiting nowThis early-stage trial is testing whether a combination of three drugs—Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone (called IoVeX)—is safe and tolerable for children and young adults (ages 1-39) whose B-cell acute lymphoblastic leukemia (B-ALL) has returned after prior tr…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Cancer patients get second chance with modified cell therapy
Disease control Recruiting nowThis study tests a modified version of a cell therapy (tisagenlecleucel) for patients with aggressive blood cancers when their manufactured treatment doesn't meet standard release specifications. It involves 200 children and adults with relapsed leukemia or lymphoma who have no o…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for leukemia patients as experimental drug enters first human tests
Disease control Recruiting nowThis is a very early study to check if a new drug called SYNCAR-100 is safe and shows any promise for adults with a specific type of leukemia that has come back or hasn't responded to other treatments. Up to 16 participants will receive four weekly doses of the drug, followed by …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 18, 2026 14:55 UTC
-
New Two-Pronged cell therapy offers hope for kids with tough leukemia
Disease control Recruiting nowThis early-stage trial is testing a new two-part cell therapy for children and young adults whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to other treatments. The therapy involves giving specially engineered immune cells (CAR-T cells) from a donor, f…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New Two-Target CAR-T therapy tested in kids with tough leukemia
Disease control Recruiting nowThis study is testing a new type of CAR-T cell therapy that targets two proteins (CD19 and CD22) on leukemia cells. It aims to find a safe dose and see if it can help children and young adults (3 months to 30 years old) whose B-cell acute lymphoblastic leukemia has come back or h…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New 'Living Drug' trial offers hope for tough blood cancers
Disease control Recruiting nowThis is a first-in-human safety study testing a new personalized cell therapy called CLIC-2201. It is for adults and children with B-cell blood cancers (like leukemia and lymphoma) that have returned or not responded to other treatments. The main goal is to find the safest and mo…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
New CAR-T therapy battle: Two-Pronged attack vs. transplant bridge for tough leukemia
Disease control Recruiting nowThis study is comparing two advanced cell therapy approaches for patients with B-cell acute lymphoblastic leukemia that has returned or not responded to previous treatments. One approach uses two different CAR-T cell infusions in sequence, while the other uses one CAR-T cell infu…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
Do cancer drugs wipe out Kids' vaccine shields? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if a common leukemia treatment called blinatumomab weakens the protection from childhood vaccines. Researchers will check antibody levels in up to 300 young patients (under 21) who have been treated for B-cell leukemia. They want to see if these pati…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC